TREA

87959850

Follow

Information

  • Trademark
  • 87959850
  • Serial Number
    87959850
  • Filing Date
    June 13, 2018
    6 years ago
  • Transaction Date
    October 18, 2019
    5 years ago
  • Status Date
    October 18, 2019
    5 years ago
  • Location Date
    October 18, 2019
    5 years ago
  • Status Code
    602
  • Current Location
    TMO LAW OFFICE 115 - EXAMINING ATTORNEY ASSIGNED
    Employee Name
    FLETCHER, TRACY L
  • Attorney Name
    Matthew J. Clark
    Law Office Assigned Location Code
    M60
  • Owners
Information
Mark Drawing Code
2000
Case File Statements
  • CC0000: Color is not claimed as a feature of the mark.
  • DM0000: The mark consists of four diagonal lines with the outer two lines being parallel and the inner two lines being collinear.
  • GS0011: (Based on 44(d) Priority Application) (Based on Intent to Use) Human stem cells for scientific purposes; Human stem cells for scientific research purposes; Human cell culture media for scientific purposes; Human cell culture media for scientific research purposes; Human embryonic stem cells for scientific purposes; Human embryonic stem cells for scientific research purposes; Human cell products, namely, pluripotent and differentiated human cells and stem cells for scientific purposes; Bioassays and cell culture media for scientific purposes; Human cell products, namely, pluripotent and differentiated human cells and stem cells for scientific research purposes; Bioassays and cell culture media for scientific research purposes; Reagents for scientific purposes; Testing reagents for scientific use; Reagents for analytical purposes, other than for medical or veterinary purposes; Laboratory reagents for scientific use; Reagents for laboratory use, other than for medical or veterinary purposes; Diagnostic reagents for scientific use; Diagnostic imaging agents for in vivo use for scientific applications other than for medical or veterinary purposes; Diagnostic imaging agents for in vivo use for scientific research purposes; Reagents for medical research applications; None of the foregoing being for use in relation to infertility or diseases, disorders, conditions, illnesses or abnormalities pertaining specifically to reproductive health; Human cell products, namely, pluripotent and differentiated human cells and stem cells for use in medical research applications; Bioassays and cell culture media for use in medical research applications
  • GS0051: (Based on 44(d) Priority Application) (Based on Intent to Use) Human stem cells for medical purposes; Human cell culture media for medical purposes; Human embryonic stem cells for medical purposes; Human cell products, namely, pluripotent and differentiated human cells and stem cells for medical purposes; Medical diagnostic bioassays; Culture media for cultivating human cells for medical purposes; Reagents for medical diagnosis; Reagents for medical diagnosis for sale in kit form; Reagents for medical analysis purposes; Reagents for medical purposes for clinical laboratory tests; Test reagents for medical use; Test reagents for medical diagnosis; Diagnostic biomarker reagents for medical purposes; Laboratory reagents for medical use; Biological products and substances for medical use, namely, pluripotent human cells for medical purposes, differentiated human cells for medical purposes, human stem cells for medical purposes, human embryonic stem cells for medical purposes, biological tissue cultures for medical purposes, reagents for medical purposes, bioassays for medical purposes, culture media for cultivating human cells for medical purposes, and mixed biological preparations for the prevention and treatment of neuromuscular diseases; Pharmaceutical preparations for the treatment of diseases and disorders of the neuromuscular system; Therapeutic pharmaceuticals for preventing and treating diseases and disorders of the neuromuscular system; Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, all the foregoing affecting humans; Diagnostic imaging agents for in vivo use for medical purposes, namely, diagnostic imaging agents for magnetic resonance imaging (MRI); Pharmaceuticals for the treatment of neuromuscular diseases and disorders, all the foregoing affecting humans; None of the foregoing being for use in relation to infertility or diseases, disorders, conditions, illnesses or abnormalities pertaining specifically to reproductive health
  • GS0091: Scientific apparatus, instruments and equipment, namely, research laboratory analyzers for measuring, testing and analyzing biological cells; Laboratory apparatus, instruments and equipment, other than for medical use, namely, research laboratory analyzers for measuring, testing and analyzing biological cells; Scientific and laboratory apparatus, instruments and equipment, other than for medical use, for scientific, pharmaceutical and biomedical research, namely, research laboratory analyzers for measuring, testing and analyzing biological cells; Scientific and laboratory apparatus, instruments and equipment, other than for medical use, for use in the diagnosis, analysis, research and treatment of diseases, medical disorders, medical conditions, illnesses, and molecular abnormalities and physical abnormalities in humans, namely, analyzers to measure skeletal muscle and motor neuron function in vitro using 2D or 3D cell culture models; Diagnostic imaging apparatus, other than for medical use, for evaluating neuromuscular health and molecular and cellular skeletal muscle dynamics, for scientific, pharmaceutical and biomedical research purposes; Imaging apparatus and equipment, other than for medical use, for use in relation to scientific, pharmaceutical and biomedical research, namely, for evaluating neuromuscular health and molecular and cellular skeletal muscle dynamics; Scientific and laboratory apparatus, instruments and equipment, other than for medical use, for use in the development and management of human cells, human cell lines, bioassays, reagents and cell culture media, namely, analyzers to measure skeletal muscle and motor neuron function in vitro using 2D or 3D cell culture models; Automated cell culture apparatus, instruments and equipment for scientific use that measure skeletal muscle and motor neuron function in vitro using 2D or 3D cell culture models; Automated cell culture apparatus, instruments and equipment for laboratory use that measure skeletal muscle and motor neuron function in vitro using 2D or 3D cell culture models; Scientific and laboratory apparatus, instruments and equipment, other than for medical use, for the development of disease models to assist with researching diseases and testing potential treatments for diseases, namely, analyzers to measure skeletal muscle and motor neuron function in vitro using 2D or 3D cell culture models; Scientific and laboratory apparatus, instruments and equipment, other than for medical use, for therapeutic drug discovery, namely, analyzers to measure skeletal muscle and motor neuron function in vitro using 2D or 3D cell culture models; Scientific and laboratory apparatus, instruments and equipment, other than for medical use, for developing treatments for diseases, medical disorders, medical conditions, illnesses, and molecular abnormalities and physical abnormalities in humans, namely, analyzers to measure skeletal muscle and motor neuron function in vitro using 2D or 3D cell culture models; Scientific and laboratory apparatus, instruments and equipment, other than for medical use, for testing pharmaceuticals and therapeutic drugs, namely, electronic analyzers for testing pharmaceutical preparations for potency; Scientific and laboratory apparatus, instruments and equipment, other than for medical use, for assessing the efficiency and safety of pharmaceuticals and therapeutic drugs, namely, electronic analyzers for testing pharmaceutical preparations for potency; None of the foregoing being for use in relation to infertility or diseases, disorders, conditions, illnesses or abnormalities pertaining specifically to reproductive health
  • GS0351: (Based on Intent to Use) Distributorship services in the fields of human cells, human cell lines, bioassays, cell culture media, reagents, pharmaceuticals and therapeutic drugs; Distributorship services in the fields of human cell products, human cell lines, bioassays, cell culture media and reagents for use by others for scientific, medical and laboratory research, diagnostic and analysis purposes other than in relation to infertility or diseases, disorders, conditions, illnesses or abnormalities pertaining specifically to reproductive health; Providing information by any means, including online, in relation to all of the foregoing; Project management services for others for business purposes in the field of scientific research projects
  • GS0391: (Based on Intent to Use) Storage of human cell products, human cell lines, bioassays, reagents and cell culture media; Distribution services, namely, delivery of human cell products, human cell lines, bioassays, cell culture media, reagents, pharmaceuticals and therapeutic drugs; Distribution services, namely, delivery of human cell products, human cell lines, bioassays, cell culture media and reagents for use by others for scientific, medical and laboratory research, diagnostic and analysis purposes; Providing information by any means, including online, in relation to all of the foregoing
  • GS0421: (Based on 44(d) Priority Application) (Based on Intent to Use) Advisory and consultancy services in the field of medical science; Scientific research; Scientific testing and research in the field of human disease, disorders and medical conditions; Medical research; Biomedical research; Laboratory research in the fields of biomedical science; Laboratory services, namely, scientific and medical research; Biotechnology research; Biological analysis and research services; Scientific and technological services, namely, scientific research, analysis and testing in the field of diseases, medical disorders, medical conditions, illnesses and molecular abnormalities affecting humans; Provision of scientific research and analysis services for others in the fields of medical science, pharmaceuticals, and therapeutic drugs; Provision of laboratory research and analysis services for others in the fields of medical science, pharmaceuticals, and therapeutic drugs; Scientific research in the nature of biotechnology analysis for others; Scientific and technological laboratory research services in the nature of product development in the field of human cell products, human cell lines, bioassays, reagents and cell culture media; Scientific and technological laboratory research services in the nature of product development in the field of human cell products, human cell lines, bioassays, reagents and cell culture media for use by others for scientific, medical and laboratory research, diagnostic and analysis purposes; Scientific and technological laboratory research services in the nature of product development in the field of collection and storage of human cell products and human cell lines; Scientific and technological laboratory research services in the nature of product development in the field of disease models to assist with researching diseases and testing potential treatments for diseases; Scientific, technological, laboratory, biotechnology, biomedical and medical research services featuring analysis and testing services in the field of therapeutic drug discovery; Scientific, technological, laboratory, biotechnology, biomedical and medical research services featuring analysis and testing services in the field of pharmaceuticals and therapeutic drugs for use by humans; Scientific, technological, laboratory, biotechnology, biomedical and medical research services featuring analysis and testing services using diagnostic imaging apparatus and equipment in the field of pharmaceuticals and therapeutic drugs for use by humans; Drug development services for the treatment of diseases, medical disorders, medical conditions, illnesses and molecular abnormalities affecting humans; Scientific and technological consultancy services relating to scientific research, medical research and laboratory research in the fields of medicine, pharmacology, chemistry, and biology; Pharmaceutical research services; Pharmaceutical testing services; Therapeutic drug research services; Therapeutic drug testing services for purposes of therapeutic drug development; Product development services in the field of pharmaceuticals and therapeutic drugs; None of the foregoing services being in relation to infertility or diseases, disorders, conditions, illnesses or abnormalities pertaining specifically to reproductive health; Providing information by any means, including online, in relation to all of the foregoing
  • GS0441: (Based on Intent to Use) Medical services in the nature of cell therapy services; Therapeutic medical treatment of the body; Therapeutic medical treatment of the body featuring the use of human cell products and human stem cells; None of the foregoing services being in relation to infertility or diseases, disorders, conditions, illnesses or abnormalities pertaining specifically to reproductive health; Providing information by any means, including online, in relation to all of the foregoing
Case File Event Statements
  • 10/18/2019 - 5 years ago
    20 - ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Type: MAB2
  • 10/18/2019 - 5 years ago
    19 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Type: ABN2
  • 3/22/2019 - 5 years ago
    18 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 3/22/2019 - 5 years ago
    17 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 3/22/2019 - 5 years ago
    16 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/13/2019 - 5 years ago
    15 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 3/7/2019 - 5 years ago
    14 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/13/2019 - 5 years ago
    13 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 3/11/2019 - 5 years ago
    12 - ASSIGNED TO LIE Type: ALIE
  • 3/7/2019 - 5 years ago
    11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 1/18/2019 - 5 years ago
    10 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 1/18/2019 - 5 years ago
    9 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 10/3/2018 - 6 years ago
    8 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 9/8/2018 - 6 years ago
    7 - NOTIFICATION OF PRIORITY ACTION E-MAILED Type: GPRN
  • 9/8/2018 - 6 years ago
    6 - PRIORITY ACTION E-MAILED Type: GPRA
  • 9/8/2018 - 6 years ago
    5 - PRIORITY ACTION WRITTEN Type: CPRA
  • 9/1/2018 - 6 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/19/2018 - 6 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 6/18/2018 - 6 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 6/16/2018 - 6 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP